Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment-Reference-Cited by-同舟云学术

Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment

Published:2013-11-19 Issue:9 Volume:21 Page:633-641
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Sprinzl M. F.¹²,Russo C.¹³,Kittner J.²,Allgayer S.¹³,Grambihler A.²,Bartsch B.²,Weinmann A.²,Galle P. R.²,Schuchmann M.²,Protzer U.¹³,Bauer T.¹³

Affiliation:

1. Institute of Virology; Technische Universität München / Helmholtz Zentrum München; Munich Germany

2. Department of Medicine; Johannes Gutenberg University; Mainz Germany

3. Clinical Cooperation Group Immune Monitoring; Technische Universität München / Helmholtz Zentrum München; German Research Center for Environmental Health; Neuerberg Germany

Funder

Helmholtz Alliance for Immunotherapy of Cancer

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12189/fullpdf

Reference24 articles.

1. Histological outcome during long-term lamivudine therapy;Dienstag;Gastroenterology,2003

2. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years;Hadziyannis;Gastroenterology,2006

3. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N Engl J Med,2004